Screening and quantification of the tumor microenvironment with micro-ultrasound and photoacoustic imaging

The family of Vevo® Imaging Systems from FUJIFILM VisualSonics, Inc. is leading to translational breakthroughs in the understanding of cancer progression and therapy. More specifically, high-frequency ultrasound and photoacoustic imaging of orthotopic and patient-derived xenograft (PDX) models of human cancer have empowered researchers in the past decade, with key translational findings on tumor growth and microenvironment and in response to new and existing cancer therapies. This Application Note focuses on the deep-tissue-imaging capabilities of micro-ultrasound and photoacoustic imaging that contributed to these translational findings.